Gentel Biosciences Powers Protein Research with New Proteomics Multi-System™

Gentel Biosciences today launched the Gentel Proteomics Multi-System™ providing “scan-to-analysis” functionality for multiplex immunoassays, lysate and antigen arrays as well as Western Blot, ELISA and tissue imaging, delivering multi-application value to researchers worldwide.

Alex Vodenlich, Gentel’s CEO, said of the system, “The Gentel Proteomics Multi-System is a game-changer in terms of functionality and affordability. It allows researchers with minimal proteomics experience or labs with limited budgets to play at a level never seen before. Gentel provides more than just an assay platform with hardware and software. We are enabling a proteomics-application workhorse that delivers reliable, reproducible results, gets you answers, and advances your research. The Proteomics Multi-System truly opens the gateway to proteomics for the non-protein researcher through its flexibility and ease of use.”

The integrated Proteomics Multi-System includes a high-resolution scanner along with a laptop computer preconfigured with image-capture and analysis software capable of data extraction and quantitation. In addition, the system allows the use of Gentel’s flagship APiX™ chromogenic reagents and slides as well as non-fluorescent proteomics products from other leading vendors.

Dr. Harry Partidos, Senior Scientist at Inviragen, Inc., and his research team leverage the Gentel Proteomics Multi-System in the development of their vaccines that protect against emerging infectious diseases. “We needed a fast and easy method for measuring cytokine levels in mouse models and the Gentel Proteomics Multi-System was a great fit for us,” Dr. Partidos said. “Gentel’s kits and system provide us with a quick profile of immune response from our precious, small-volume samples. It’s a very practical way to measure 12 cytokines simultaneously,” stated Partidos.